Chelsea Weidman Burke - Profile and Journalist Details

Beats

Biography

I'm a biochemist turned science communicator who is passionate about education and lifelong learning. Bylines: Alzforum, BioSpace, BrightFocus Foundation, Science in the News at Harvard University, Massive Science Editing experience: Assistant Editor for Harvard University's short-form blog Science in the News Deliverables: short-form and feature news articles, disease/drug pipeline reports, articles designed for student learning, conference summary reports, newsletters, and encyclopedia entries Research/teaching experience: academic researcher (8 years), teaching assistant (4 years), and chemistry tutor When I'm not reading or writing about science, you can find me tweeting (@ChemInquisitive) and instagraming (@chem.inquisitive) about it! I also enjoy reading (non-scientific topics), cross-stitching, watching hockey, and staying active with fitness classes.

Content

Total articles 69

• Stem Cells May Help COVID-19 and ARDS Patients Breathe Easier

  By Chelsea Weidman Burke Verified

  Sep. 15, 2020

• Untangling the Body’s Smart Sensors: What RNA Binding Proteins Can Tell Us About Gene Regulation

  By Chelsea Weidman Burke Verified

  Sep. 11, 2020

• Cystic Fibrosis: One Patient’s Story, Current Treatments and Exciting New Therapies on the Horizon

  By Chelsea Weidman Burke Verified

  May. 11, 2021

As seen in

Company Info

Alzforum

Alzforum is an independent, nonprofit organization based in Boston, MA, dedicated to advancing Alzheimer’s disease research through collaborative knowledge-sharing and data curation. As the Alzforum Foundation Inc., it serves as a global hub for researchers, clinicians, and stakeholders in neurodegenerative diseases, emphasizing open-access resources and community-driven insights. The organization offers several key services, including curated research databases like AlzBiomarkers, which tracks biomarkers for Alzheimer’s diagnosis and progression, and a Therapeutics Database that monitors drug development and clinical trials. Alzforum also provides editorial resources such as news coverage, webinars, and discussions to facilitate dialogue among researchers. Community initiatives like the Alzheimer’s Disease Data Initiative (ADDI) promote data-sharing and interoperability in clinical trials, enhancing collaboration across the field. Alzforum primarily serves academic researchers, pharmaceutical companies, clinicians, and nonprofit organizations, helping them access valuable tools and information to support their work in Alzheimer’s research.